NIH's R21 grant supports early-stage, high-risk clinical trial research with potential for breakthroughs in biomedical, behavioral, or clinical fields.
NIH grant supports focused research projects requiring at least one clinical trial, aligning with the scientific interests of participating NIH Institutes and Centers.
NIH grant supports specific research projects aligned with NIH Institutes' missions, but excludes clinical trials.
NIH plans a milestone-driven award supporting planning and early to definitive clinical trials across biomedical and other interventions for up to 7 years; applications are not yet being accepted.
This grant supports investigator-initiated clinical trials to reduce cancer burden through early detection, prevention, and survivorship improvements.
NIH funds domestic institutions to provide mentored biomedical and behavioral research career development for later-stage postdocs and junior faculty; scholars cannot lead independent clinical trials.